Weekly Recap: Q2 APE, VNB and profit gains and Emkay Buy, Rs2,150 tgt

What happened

SBI Life Insurance reported Q2 growth in annual premium equivalent (APE), higher value of new business (VNB) and VNB margins, and increased quarterly net profit and first-half profit after tax. Its solvency ratio was about 1.97x. Emkay retained a Buy rating and a September 2027 target of Rs 2,150, implying roughly 32% upside.

Confirmed

Global impact / market context

Higher VNB and margins indicate stronger value from new policies, while higher profit adds to reported earnings. If these gains continue, they could support SBI Life’s capacity to fund operations and distributions; however, the recap provides no detailed figures or evidence that the improvement will persist.

Analyst inference

Emkay’s Buy rating and Rs 2,150 target are an analyst view, not a guaranteed outcome; its stated roughly 32% upside depends on the share price used. The recap also cites an estimated price-to-embedded-value ratio of about 1.9x, comparing the share price with an insurer’s business value.

Analyst inference

What to watch

1. Look for the full Q2 results to quantify APE, VNB, margins, profit and first-half profit after tax, since the recap gives no detailed growth rates or amounts. Analyst inference
2. Check whether SBI Life’s solvency ratio remains near the reported 1.97x; solvency measures an insurer’s capacity to meet obligations, but no trend is supplied here. Analyst inference
3. Compare later Emkay updates with its retained Buy rating and September 2027 Rs 2,150 target to see whether its earnings estimates or valuation view changes. Analyst inference

Evidence

• Original source link unavailable